Four pharmacologically distinct subtypes of α4β2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes

Molecular Pharmacology

Volumn 54, Issue 6, 1998, Pages 1124-1131

  Zwart, Ruud ^a   Vijverberg, Henk P M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; COMPLEMENTARY DNA; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; TUBOCURARINE CHLORIDE;

ANIMAL CELL; ARTICLE; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ION CURRENT; NONHUMAN; OOCYTE; PRIORITY JOURNAL; STOICHIOMETRY; VOLTAGE CLAMP; XENOPUS LAEVIS;

EID: 0032426910     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.6.1124     Document Type: Article

References (15)

1. Anand R, Conroy WG, Schoepfer R, Whiting P, and Lindstrom J (1991) Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure. J Biol Chem 266:11192-11198.
2. Bertrand D, Ballivet M, and Rungger D (1990) Activation and blocking of neuronal nicotinic acetylcholine receptor reconstituted in Xenopus oocytes. Proc Natl Acad Sci USA 87:1993-1997.
3. Bertrand D and Changeux JP (1995) Nicotinic receptor: an allosteric protein specialized for intercellular communication. Semin Neurosci 7:75-90.
4. Bertrand D, Cooper E, Valera S, Rungger D, and Ballivet M (1991) Electrophysiology of neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes following nuclear injection of genes or cDNAs. Methods Neurosci 4:174-193.
5. Blount P and Merlie JP (1989) Molecular basis of the two nonequivalent ligand binding sites of the muscle nicotinic receptors. Neuron 3:349-357.
6. Buisson B and Bertrand D (1998) Open-channel blockers at the human α4β2 neuronal nicotinic acetylcholine receptor. Mol Pharmacol 53:555-563.
7. Buller AL and White MM (1990) Functional acetylcholine receptors expressed in Xenopus oocytes after injection of Torpedo β, γ, and δ subunit RNAs are a consequence of endogenous oocyte gene expression. Mol Pharmacol 37:423-428.
8. Charnel P, Labarca C, Cohen BN, Davidson N, Lester HA, and Pilar G (1992) Pharmacological and kinetic properties of α4β2 neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Physiol (Lond) 450:375-394.
9. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, and Johnson EC (1997) Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280:346-356.
10. Colquhoun D, Dryer F, and Sheridan RE (1979) The actions of tubocurarine at the frog neuromuscular junction. J Physiol (Lond) 293:247-284.
11. Colquhoun D and Ogden DC (1988) Activation of ion channels in the frog end-plate by high concentrations of acetylcholine. J Physiol (Lond) 395:131-159.
12. Cooper E, Couturier S, and Ballivet M (1991) Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature (Lond) 350: 235-238.
13. Whiting P, Schoepfer R, Lindstrom J, and Priestley T (1990) Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts. Mol Pharmacol 40:463-472.
14. Zwart R, Oortgiesen M, and Vijverberg HPM (1995) Differential modulation of α3β2 and α3β4 neuronal nicotinic receptors expressed in Xenopus oocytes by flufenamic acid and niflumic acid. J Neurosci 15:2168-2178.
15. Zwart R and Vijverberg HPM (1997) Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects. Mol Pharmacol 52:886-895.